Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...
Axsome Therapeutics has begun the Phase 3 CLARITY trial of solriamfetol in adults with major depressive disorder and excessive daytime sleepiness. The study focuses on a patient group that currently ...
Obstructive sleep apnoea may affect 1 in 5 adults in the UK and USA, costing billions in lost productivity, but can be offset by effective treatment.
Obstructive sleep apnea is a serious medical condition characterized by airway obstruction during sleep. In addition to increased risk of physical health concerns such as heart attack and stroke, it ...
Experts have outlined crucial signs that might indicate snoring is a symptom of a more concerning underlying problem ...
MARYSVILLE, OH - February 24, 2026 - PRESSADVANTAGE - Sleep Better Marysville has announced the expansion of its sleep ...
Untreated obstructive sleep apnea may be costing the UK and US economies billions of pounds/dollars in lost productivity ...
Anatomy, lifestyle and physiology are the three main factors that can cause snoring, according to Dr Ryan Chin Taw Cheong, ...
Around 1 in 5 adults in both countries may have the condition, analysis suggestsTime to test workplace screening in those most at risk of harm from ...
A 14-year-old boy and his mother went to his pediatrician because the teen had just been placed on a three-day suspension. The reason? His loud snoring was disrupting his classes. His doctor asked ...
JAZZ CBD drug Epidiolex tops $1B in annual sales, boosting revenue visibility and cannabis exposure. Is the biotech's growth story just beginning?
Dr. Kaloji is visiting Svims as part of Srivari Vaidya Seva, a voluntary medical service initiative introduced by the Tirumala Tirupati Devasthanams (TTD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results